Category: Other
Throughout the past two decades, ACIST has made an impact on the well-being of 35 million patients across more than 75 countries. The ACIST CVi® Contrast Delivery System has been instrumental in reducing the occurrence of contrast-induced acute kidney injury (CI-AKI) by up to 30%. The RXi® Rapid Exchange FFR System, which can be equipped with dPR* (Non-Hyperemic Index for Coronary Physiology), uses the Navvus II® MicroCatheter allowing operators to employ their .014″ guidewire of choice. Furthermore, the HDI® HD IVUS System provides an expanded field of view and superior imaging capabilities, providing enhanced deliverability and optimized imaging with the Kodama® HD IVUS Catheter.
*not available in all global markets, including the United States
Note: See full resource above for complete citations and references.
ACIST informs interventional decisions during cardiovascular disease, structural heart, and peripheral procedures. The ACIST CVi® Contrast Delivery System, RXi® Rapid Exchange FFR System with dPR* (the Non-Hyperemic Index for Coronary Physiology) and the Navvus II® MicroCatheter, and the HDI® HD IVUS System with the Kodama® HD IVUS Catheter give physicians worldwide the ability to visualize, assess and inform patient treatment. CVi® increases safety and overall operational efficiency during the contrast delivery process. RXi® is used to efficiently assess, and confirm coronary artery disease, even in the most complex cases. HDi® is the system of choice for optimized imaging in percutaneous coronary and peripheral interventions.
Physicians worldwide rely on our diagnostic technologies to give them the power to visualize, assess and inform patient treatment. Economic decision-makers appreciate our ability to demonstrate the value of therapeutic intervention.
*not available in all global markets, including the United States
